Moody Aldrich Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,138	Closed	-$320K	–	196
2024 Q1	$320K	Sell	2,138 -1,147	-35%	-$171K	0.05%	171
2023 Q4	$629K	Buy	3,285 +1,002	+44%	+$192K	0.11%	126
2023 Q3	$404K	Buy	+2,283	New	+$404K	0.08%	140